全文获取类型
收费全文 | 16061篇 |
免费 | 2529篇 |
国内免费 | 165篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 526篇 |
妇产科学 | 290篇 |
基础医学 | 1799篇 |
口腔科学 | 86篇 |
临床医学 | 1426篇 |
内科学 | 3893篇 |
皮肤病学 | 142篇 |
神经病学 | 432篇 |
特种医学 | 390篇 |
外科学 | 369篇 |
综合类 | 760篇 |
现状与发展 | 8篇 |
预防医学 | 7541篇 |
眼科学 | 50篇 |
药学 | 596篇 |
2篇 | |
中国医学 | 20篇 |
肿瘤学 | 412篇 |
出版年
2024年 | 56篇 |
2023年 | 633篇 |
2022年 | 798篇 |
2021年 | 901篇 |
2020年 | 1277篇 |
2019年 | 729篇 |
2018年 | 753篇 |
2017年 | 626篇 |
2016年 | 794篇 |
2015年 | 926篇 |
2014年 | 1167篇 |
2013年 | 888篇 |
2012年 | 906篇 |
2011年 | 939篇 |
2010年 | 837篇 |
2009年 | 730篇 |
2008年 | 661篇 |
2007年 | 774篇 |
2006年 | 668篇 |
2005年 | 612篇 |
2004年 | 537篇 |
2003年 | 467篇 |
2002年 | 398篇 |
2001年 | 391篇 |
2000年 | 376篇 |
1999年 | 341篇 |
1998年 | 124篇 |
1997年 | 85篇 |
1996年 | 106篇 |
1995年 | 70篇 |
1994年 | 48篇 |
1993年 | 35篇 |
1992年 | 26篇 |
1991年 | 11篇 |
1990年 | 6篇 |
1989年 | 8篇 |
1988年 | 13篇 |
1987年 | 18篇 |
1986年 | 17篇 |
1985年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
33.
BackgroundThe Affordable Care Act (ACA) Medicaid expansion varies in availability across states.PurposeWe compared characteristics of low-income uninsured residents in both Medicaid nonexpanding and expanding states with respect to their dietary quality, health risk factors, and access to care.MethodsData from the 2007–2012 National Health and Nutrition Examination Survey was matched with the Kaiser Family Foundation Medicaid expansion data. Bivariate and multivariate regressions were estimated to assess differences across expanding and non-expanding states.ResultThe non-expansion group had a lower Healthy Eating Index score (41.8 vs. 44.1, p-value = 0.006), a higher Body Mass Index (29.9 vs. 28.9, p-value = 0.032), higher obesity prevalence (41% vs. 33%, p-value = 0.007), and lower asthma prevalence (14.8% vs. 19.7%, p-value = 0.037) compared with the expansion group.ConclusionsDifferences across states in Medicaid coverage under the ACA may lead to widening disparities in health outcomes between expanding and non-expanding states. 相似文献
34.
35.
36.
《Vaccine》2020,38(51):8185-8193
BackgroundWhile administration of the measles-mumps-rubella (MMR-II®) vaccine has been effective at preventing rubella infection in the United States, the durability of humoral immunity to the rubella component of MMR vaccine has not been widely studied among older adolescents and adults.MethodsIn this longitudinal study, we sought to assess the durability of rubella virus (RV)-specific humoral immunity in a healthy population (n = 98) of adolescents and young adults at two timepoints: ~7 and ~17 years after two doses of MMR-II® vaccination. Levels of circulating antibodies specific to RV were measured by ELISA and an immune-colorimetric neutralization assay. RV-specific memory B cell responses were also measured by ELISpot.ResultsRubella-specific IgG antibody titers, neutralizing antibody titers, and memory B cell responses declined with increasing time since vaccination; however, these decreases were relatively moderate. Memory B cell responses exhibited a greater decline in men compared to women.ConclusionsCollectively, rubella-specific humoral immunity declines following vaccination, although subjects’ antibody titers remain well above the currently recognized threshold for protective immunity. Clinical correlates of protection based on neutralizing antibody titer and memory B cell ELISpot response should be defined. 相似文献
37.
38.
《Vaccine》2016,34(50):6316-6322
ObjectiveAir pollution, weather condition and influenza are known risk factors of acute coronary syndrome (ACS) among elderly people. The influenza vaccine (IV) has been shown to reduce major cardiovascular events. The purpose of this study was to compare resistance to air pollution and weather factors causing ACS between vaccinated and less-vaccinated elderly people.MethodsA case–crossover design was applied to 1835 elderly ACS patients who were obtained from the 1-million sample of Taiwan National Health Insurance Research Data with inclusion criteria: (1) the first diagnosis of ACS was in cold season and at age 68 or more, (2) had received the free IV program at least once during the period 3 years before the ACS. They were stratified into two groups: 707 had received flu vaccinations for all the 3 years and the remaining 1128 had not. The measurements of air pollutants, temperature, and humidity corresponding to each of the 3 days prior to the ACS diagnosis date were retrieved from the data banks of the Taiwan Environmental Protection Administration and Central Weather Bureau.FindingsIncreases in air pollution concentrations of CO, NO2, PM10 or PM2.5 and decreases in temperature significantly influenced the risk of ACS for the non-continuously vaccinated elderly population; however, less significant effects were observed for the continuously vaccinated population.ConclusionConsecutive influenza vaccination may potentially offer resistance against the detrimental effects of air pollution and changes in temperature in frail elderly adults with ACS. Future studies are needed to directly assess the interaction effect between the vaccination and environmental factors on ACS. 相似文献
39.
《Vaccine》2016,34(8):1115-1125
Chronic hepatitis C virus (HCV) infection represents a major health threat to global population. In India, approximately 15–20% of cases of chronic liver diseases are caused by HCV infection. Although, new drug treatments hold great promise for HCV eradication in infected individuals, the treatments are highly expensive. A vaccine for preventing or treating HCV infection would be of great value, particularly in developing countries. Several preclinical trials of virus-like particle (VLP) based vaccine strategies are in progress throughout the world. Previously, using baculovirus based system, we have reported the production of hepatitis C virus-like particles (HCV-LPs) encoding structural proteins for genotype 3a, which is prevalent in India. In the present study, we have generated HCV-LPs using adenovirus based system and tried different immunization strategies by using combinations of both kinds of HCV-LPs with other genotype 3a-based immunogens. HCV-LPs and peptides based ELISAs were used to evaluate antibody responses generated by these combinations. Cell-mediated immune responses were measured by using T-cell proliferation assay and intracellular cytokine staining. We observed that administration of recombinant adenoviruses expressing HCV structural proteins as final booster enhances both antibody as well as T-cell responses. Additionally, reduction of binding of VLP and JFH1 virus to human hepatocellular carcinoma cells demonstrated the presence of neutralizing antibodies in immunized sera. Taken together, our results suggest that the combined regimen of VLP followed by recombinant adenovirus could more effectively inhibit HCV infection, endorsing the novel vaccine strategy. 相似文献
40.